{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:52:47Z","timestamp":1768038767125,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s10157-019-01712-x","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T01:54:35Z","timestamp":1550022875000},"page":"465-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA"],"prefix":"10.1007","volume":"23","author":[{"given":"Hajime","family":"Kaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Komatsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soh","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Odaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Wakui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"1712_CR1","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/S0140-6736(15)60731-0","volume":"385","author":"P Ronco","year":"2015","unstructured":"Ronco P, Debiec H. Pathophysiological advances in membranous nephropathy: time for a shift in patient\u2019s care. Lancet. 2015;385:1983\u201392.","journal-title":"Lancet"},{"key":"1712_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1053\/j.ajkd.2016.01.030","volume":"68","author":"JM Francis","year":"2016","unstructured":"Francis JM, Beck LH Jr, Salant DJ. Membranous nephropathy: a journey from bench to bedside. Am J Kidney Dis. 2016;68:138\u201347.","journal-title":"Am J Kidney Dis"},{"key":"1712_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11\u201321.","journal-title":"N Engl J Med"},{"key":"1712_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10157-014-1054-2","volume":"19","author":"S Akiyama","year":"2015","unstructured":"Akiyama S, Akiyama M, Imai E, Ozaki T, Matsuo S, Maruyama S. Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Clin Exp Nephrol. 2015;19:653\u201360.","journal-title":"Clin Exp Nephrol"},{"key":"1712_CR5","doi-asserted-by":"publisher","first-page":"e0158154","DOI":"10.1371\/journal.pone.0158154","volume":"11","author":"K Hihara","year":"2016","unstructured":"Hihara K, Iyoda M, Tachibana S, Iseri K, Saito T, Yamamoto Y, et al. Anti-phospholipase A2 receptor (PLA2R) antibody and glomerular PLA2R expression in Japanese patients with membranous nephropathy. PLoS One. 2016;11:e0158154.","journal-title":"PLoS One"},{"key":"1712_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cca.2013.03.015","volume":"421","author":"C D\u00e4hnrich","year":"2013","unstructured":"D\u00e4hnrich C, Komorowski L, Probst C, Seitz-Polski B, Esnault V, Wetzels JF, et al. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta. 2013;421:213\u20138.","journal-title":"Clin Chim Acta"},{"key":"1712_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1309\/AJCP8QMOY5GLRSFP","volume":"142","author":"SA Timmermans","year":"2014","unstructured":"Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, Ayalon R, Beck LH Jr, Schlumberger W, et al. Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy. Am J Clin Pathol. 2014;142:29\u201334.","journal-title":"Am J Clin Pathol"},{"key":"1712_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revised. J Am Soc Nephrol. 2004;15:241\u201350.","journal-title":"J Am Soc Nephrol"},{"key":"1712_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/ajkd.2002.31987","volume":"39","author":"K Nagahama","year":"2002","unstructured":"Nagahama K, Matsushita H, Hara M, Ubara Y, Hara S, Yamada A. Bucillamine induces membranous glomerulonephritis. Am J Kidney Dis. 2002;39:706\u201312.","journal-title":"Am J Kidney Dis"},{"key":"1712_CR10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"A Matsuo","year":"2009","unstructured":"Matsuo A, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"1712_CR11","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1681\/ASN.2014070640","volume":"26","author":"P Ruggenenti","year":"2015","unstructured":"Ruggenenti P, Debiec H, Ruggiero B, Chianca A, Pell\u00e9 T, Gaspari F, et al. Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. J Am Soc Nephrol. 2015;26:2545\u201358.","journal-title":"J Am Soc Nephrol"},{"key":"1712_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000440983","volume":"42","author":"YG Kim","year":"2015","unstructured":"Kim YG, Choi YW, Kim SY, Moon JY, Ihm CG, Lee TW, et al. Anti-phospholipase A2 receptor antibody as prognostic indicator in idiopathic membranous nephropathy. Am J Nephrol. 2015;42:250\u20137.","journal-title":"Am J Nephrol"},{"key":"1712_CR13","doi-asserted-by":"crossref","unstructured":"Dou Y, Zhang L, Liu D, Wang C, Quan S, Ma S, et al. The accuracy of the anti-phospholipase A2 receptor antibody in the diagnosis of idiopathic membranous nephropathy: a comparison of different cutoff values as measured by the ELISA method. Int Urol Nephrol. 2016:48; 845\u20139.","DOI":"10.1007\/s11255-016-1263-6"},{"key":"1712_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1681\/ASN.2010090967","volume":"22","author":"W Qin","year":"2011","unstructured":"Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22:1137\u201343.","journal-title":"J Am Soc Nephrol"},{"key":"1712_CR15","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1093\/ndt\/gfr247","volume":"26","author":"E Hoxha","year":"2011","unstructured":"Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K. e al. An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transpl. 2011;26:2526\u201332.","journal-title":"Nephrol Dial Transpl"},{"key":"1712_CR16","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1681\/ASN.2012030242","volume":"23","author":"JM Hofstra","year":"2012","unstructured":"Hofstra JM, Debiec H, Short CD, Pell\u00e9 T, Kleta R, Mathieson PW, et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol. 2012;23:1735\u201343.","journal-title":"J Am Soc Nephrol"},{"key":"1712_CR17","doi-asserted-by":"publisher","first-page":"e62151","DOI":"10.1371\/journal.pone.0062151","volume":"8","author":"YJ Oh","year":"2013","unstructured":"Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One. 2013;8:e62151.","journal-title":"PLoS One"},{"key":"1712_CR18","doi-asserted-by":"publisher","first-page":"e61669","DOI":"10.1371\/journal.pone.0061669","volume":"8","author":"A Behnert","year":"2013","unstructured":"Behnert A, Fritzler MJ, Teng B, Zhang M, Bollig F, Haller H, et al. An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor. PLoS One. 2013;8:e61669.","journal-title":"PLoS One"},{"key":"1712_CR19","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ki.2012.486","volume":"83","author":"D Kanigcherla","year":"2013","unstructured":"Kanigcherla D, Gummadova J, McKenzie EA, Roberts AS, Harris S, Nikam M, et al. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int. 2013;83:940\u20138.","journal-title":"Kidney Int"},{"key":"1712_CR20","doi-asserted-by":"crossref","unstructured":"Behnert A, Schiffer M, M\u00fcller-Deile J, Beck LH Jr, Mahler M, Fritzler M. Antiphospholipase A2 receptor antibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy. J Immunol Res. 2014; 2014:143274.","DOI":"10.1155\/2014\/143274"},{"key":"1712_CR21","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013040430","volume":"25","author":"E Hoxha","year":"2014","unstructured":"Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RA. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol. 2014;25:1357\u201366.","journal-title":"J Am Soc Nephrol"},{"key":"1712_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.biochi.2015.08.007","volume":"118","author":"B Seiz-Polski","year":"2015","unstructured":"Seiz-Polski B, Dolla G, Payr\u00e9 C, Tomas NM, Lochouarn M, Jeammet L, et al. Cross-reactivity of anto-PLA2R autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy. Biochimie. 2015;118:104\u201315.","journal-title":"Biochimie"},{"key":"1712_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.pathol.2016.02.001","volume":"48","author":"L Ong","year":"2016","unstructured":"Ong L, Silvestrini R, Chapman J, Fulcher DA, Lin MW. Validation of a phospholipase A2 receptor antibody ELISA in an Australian cohort with membranous nephropathy. Pathology. 2016;48:242\u20136.","journal-title":"Pathology"},{"key":"1712_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000445361","volume":"43","author":"SY Wei","year":"2016","unstructured":"Wei SY, Wang YX, Li JS, Zhao SL, Diao TT, Wang Y, et al. Serum anti-PLA2R antibody predicts treatment outcome in idiopathic membranous nephropathy. Am J Nephrol. 2016;43:129\u201340.","journal-title":"Am J Nephrol"},{"key":"1712_CR25","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.12659\/MSM.896090","volume":"22","author":"X Li","year":"2016","unstructured":"Li X, Wei D, Zhou Z, Wang B, Xu Y, Pan J, et al. Anti-PLA2R antibodies in Chinese patients with membranous nephropathy. Ned Sci Monit. 2016;22:1630\u20136.","journal-title":"Ned Sci Monit"},{"key":"1712_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/ckj\/sfw121","volume":"10","author":"P Jullien","year":"2017","unstructured":"Jullien P, Seiz Polski B, Maillard N, Thibaudin D, Laurent B, Ollier E, et al. Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy. Clin Kidney J. 2017;10:209\u201314.","journal-title":"Clin Kidney J"},{"key":"1712_CR27","doi-asserted-by":"publisher","first-page":"e7218","DOI":"10.1097\/MD.0000000000007218","volume":"96","author":"L Pang","year":"2017","unstructured":"Pang L, Zhang AM, Li HX, Du JL, Jiao LL, Duan N, et al. Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: a cross-sectional study. Medicine (Baltimore). 2017;96:e7218.","journal-title":"Medicine (Baltimore)"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-019-01712-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01712-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01712-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:39:24Z","timestamp":1581554364000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-019-01712-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1712"],"URL":"https:\/\/doi.org\/10.1007\/s10157-019-01712-x","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"18 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors have declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number 1026), and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}